GlaxoSmithKline | GSK

Stock Price
1,634.50
Daily Change
-6.00 -0.37%
Monthly
-4.15%
Yearly
13.74%
Q2 Forecast
1,679.38
Peers Price Chg Day Year Date
ABBV AbbVie 167.20 -0.81 -0.48% 3.34% Apr/25
ALC Alcon AG 71.70 0.14 0.20% 12.67% Apr/26
ALM Almirall 8.54 0.07 0.83% -7.58% Apr/26
AMGN Amgen 269.42 -3.72 -1.36% 12.82% Apr/25
ARGX argenx SE 344.30 -1.90 -0.55% 0.44% Apr/26
AZN AstraZeneca 11,968.00 -58.00 -0.48% 1.46% Apr/26
BAYN Bayer 27.34 0.44 1.64% -54.23% Apr/26
BIIB Biogen 202.49 0.36 0.18% -29.70% Apr/25
BMY Bristol-Myers Squibb 44.70 -4.16 -8.51% -34.28% Apr/25
FME Fresenius Medical Care 37.99 0.20 0.52% -10.79% Apr/26
FRE Fresenius 26.98 -0.20 -0.74% 3.77% Apr/26
GEN Genmab 1,961.00 45.50 2.38% -29.26% Apr/26
GILD Gilead Sciences 65.07 -1.83 -2.73% -22.30% Apr/25
GLPG Galapagos 26.58 0.02 0.08% -24.27% Apr/26
GRF GRIFOLS 8.32 0.24 2.92% -8.13% Apr/26
GSK GlaxoSmithKline 1,634.50 -6.00 -0.37% 13.74% Apr/26
HIK Hikma Pharmaceutical 1,900.00 46.00 2.48% 7.34% Apr/26
LLY Eli Lilly 729.01 -8.11 -1.11% 93.75% Apr/25
LONN Lonza 521.00 7.20 1.40% -5.20% Apr/26
MRK Merck 152.05 1.95 1.30% -5.21% Apr/26
MRK Merck 130.49 3.59 2.83% 15.04% Apr/25
NOVN Novartis 89.37 -0.63 -0.70% -2.17% Apr/26
ORNBV Orion 35.73 0.27 0.76% -17.99% Apr/26
PFE Pfizer 25.26 -0.97 -3.69% -34.61% Apr/25
PHIA Philips 19.41 0.14 0.73% 1.27% Apr/26
REC Recordati 49.06 0.26 0.53% 18.76% Apr/26
REGN Regeneron Pharmaceuticals 906.54 -16.99 -1.87% 16.52% Apr/25
ROG Roche Holding 219.40 0.60 0.27% -20.56% Apr/26
SAN Sanofi 89.66 -1.96 -2.14% -11.94% Apr/26
SN Smith & Nephew 974.00 9.60 1.00% -24.41% Apr/26
UCB UCB 122.20 -2.90 -2.32% 42.86% Apr/26

Indexes Price Day Year Date
UKX GB100 8118 38.84 0.48% 3.65% Apr/26

GlaxoSmithKline traded at 1,640.75 this Friday April 26th, increasing 0.25 or 0.02 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline gained 3.78 percent. Over the last 12 months, its price rose by 14.18 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,679.38 by the end of this quarter and at 1,594.70 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.